- Home
- ZIM vs TARS Comparison
ZIM vs TARS Comparison
Compare ZIM & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZIM | TARS |
|---|---|---|
| Founded | 1945 | 2016 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.8B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ZIM | TARS |
|---|---|---|
| Price | $20.04 | $81.96 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | $12.45 | ★ $73.63 |
| AVG Volume (30 Days) | ★ 6.2M | 388.0K |
| Earning Date | 11-20-2025 | 11-04-2025 |
| Dividend Yield | ★ 35.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.31 | N/A |
| Revenue | ★ $7,587,100,000.00 | $366,100,000.00 |
| Revenue This Year | N/A | $147.24 |
| Revenue Next Year | N/A | $53.11 |
| P/E Ratio | $2.45 | ★ N/A |
| Revenue Growth | 1.63 | ★ 182.44 |
| 52 Week Low | $11.04 | $38.51 |
| 52 Week High | $23.61 | $83.47 |
Technical Indicators
Market Signals| Indicator | ZIM | TARS |
|---|---|---|
| Relative Strength Index (RSI) | 70.65 | 67.40 |
| Support Level | $18.82 | $77.44 |
| Resistance Level | $21.00 | $82.90 |
| Average True Range (ATR) | 0.92 | 3.51 |
| MACD | 0.20 | 0.09 |
| Stochastic Oscillator | 80.18 | 87.44 |
Price Performance
Historical ComparisonAbout ZIM ZIM Integrated Shipping Services Ltd.
ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.